The urine protein excretion level in host mice treated with tacrolimus or IL-2 IC plus tacrolimus at 8 weeks after GVHD induction was reduced compared with that in control mice, but not significantly (Figure 2D). This evidence concerns the gene IL2 and graft versus host disease.